home / stock / knbwy / knbwy news


KNBWY News and Press, Kirin Holdings Co Ltd ADR

Stock Information

Company Name: Kirin Holdings Co Ltd ADR
Stock Symbol: KNBWY
Market: OTC

Menu

KNBWY KNBWY Quote KNBWY Short KNBWY News KNBWY Articles KNBWY Message Board
Get KNBWY Alerts

News, Short Squeeze, Breakout and More Instantly...

KNBWY - Expected US Company Earnings on Thursday, May 9th, 2024

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

KNBWY - Expected US Company Earnings on Tuesday, February 13th, 2024

ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...

KNBWY - Catalyst Watch: Spotlight on FedEx, Nike, Micron and gold stocks

2023-12-15 15:10:23 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week, or the Seeking Alpha earnings calendar ...

KNBWY - Orchard says no FDA AdCom for gene therapy approval

2023-11-21 08:46:55 ET More on Orchard Therapeutics Orchard Therapeutics: A Reassessment Biggest stock movers today: BlackBerry, Clorox, Rivian Automotive and more Kyowa Kirin to buy Orchard Therapeutics for $387M Seeking Alpha’s Quant Rating on Orchar...

KNBWY - Expected US Company Earnings on Wednesday, November 8th, 2023

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

KNBWY - Expected earnings - Kirin Holdings Co., Ltd. ADR

Kirin Holdings Co., Ltd. ADR (KNBWY) is expected to report for Q3 2023

KNBWY - Kyowa Kirin to buy Orchard Therapeutics for $387M

2023-10-05 05:24:47 ET More on both companies Orchard Therapeutics: A Reassessment Orchard Therapeutics: Highly Valued Once, Undervalued Today Orchard Therapeutics stock jumps 13% as FDA accepts BLA for OTL-200 For further details see: Kyowa Kirin to buy ...

KNBWY - Kyowa Kirin: High-Risk High-Return Call Reiterating Our Buy Rating

2023-09-24 23:33:31 ET Summary Kyowa Kirin shares are viewed as a cheap option on the positive outcome for the atopic dermatitis drug being developed with Amgen. The company's recent track record for new drug trial success has been poor, but the partnership with Amgen provides rea...

KNBWY - Kirin Holdings Company, Limited GAAP EPS of ¥39.49, revenue of ¥970.23B

2023-08-08 07:05:56 ET Kirin Holdings Company, Limited press release ( OTCPK:KNBWY ): 1H GAAP EPS of ¥39.49. Revenue of ¥970.23B (+5.8% Y/Y). For further details see: Kirin Holdings Company, Limited GAAP EPS of ¥39.49, revenue of ¥970.23B

KNBWY - Kirin Holdings: Improving Earnings Trajectory With Proactive Management

2023-04-25 04:31:23 ET Summary Kirin Holdings is executing positive price hikes, business portfolio management, and a greater commitment to raising profitability. Earnings visibility looks positive, with continued price increases in beverages, steady overseas expansion, and steady...

Next 10